Indications

SOMATULINE AUTOGEL is indicated for the long term treatment of individuals with acromegaly when the circulating levels of Growth Hormone (GH) and/or Insulin-like Growth Factor-1 (IGF-1) remain abnormal after surgery and/or radiotherapy, or in patients who otherwise require medical treatment. The goal of treatment in acromegaly is to reduce GH and IGF-1 levels and where possible to normalise these values.

SOMATULINE AUTOGEL is indicated for the relief of symptoms associated with acromegaly.

SOMATULINE AUTOGEL is also indicated for the treatment of symptoms associated with carcinoid tumours.

The injection may be given by a healthcare professional or, for patients who are receiving a stable dose of Somatuline Autogel, by an appropriately trained friend or relative of the patient. Alternatively, patients who have received appropriate training may self-administer the product.   

FULL PRESCRIBING INFORMATION

In compliance with the guidelines of the Irish Pharmaceutical Healthcare Association, the self-regulatory body of the pharmaceutical industry in Ireland, the full prescribing information for all of Ipsen's products in Ireland are available now on www.medicines.ie